Neoadjuvant chemotherapy of breast carcinomas: What post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?;Neoadjuvante chemotherapie des mammakarzinoms: Welche posttherapeutischen (präoperativen) informationen liefert die quantitative dynamische MRT?

Radiologe

Volumn 47, Issue 5, 2007, Pages 421-429

  Wasser, K ^a,b   Klein, S K ^c   Junkermann, H ^d   Sinn, H P ^e   Darai, S ^c   Neff, W ^b   Kauczor, H U ^a   Delorme, S ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d Zentralkrankenhaus Bremen ^*  (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Dynamic magnetic resonance imaging (dMRI); Mammography; Neoadjuvant chemotherapy; Ultrasound

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CARCINOMA; CANCER REGRESSION; CANCER SIZE; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONTRAST MEDIA; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 34250159506     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-005-1303-1     Document Type: Article

References (27)

1. Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72:145-52
2. Brix G, Schreiber W, Hoffmann U, Gückel F, Hawighorst H, Knopp MV (1997) Methodische Ansätze zur quantitativen Beurteilung der Mikrozirkulation im Gewebe mit der dynamischen Magnetresonanztomographie. Radiologe 37:470-480
3. Cheung YC, Chen SC, Su MY, See LC, Hsueh S, Chang HK, Lin YC, Tsai CS (2003) Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 78:51-58
4. Conolly JL, Schnitt SJ (1988) Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer. Pathol Annu 23:1-23
5. Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, Fox JN (2001) Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 27:617-620
6. Gasparini G (2001) Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2:733-740
7. Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schönberg SO, Vaupel P, van Kaick G (1998) Angiogenetic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4:2305-2312
8. Hess T, Knopp MV, Hoffmann U, Brix G, Junkermann H, Zuna I, von Fournier D, van Kaick G (1994) Pharmakokinetische Analyse der Gd-DTPA-Anreicherung in der MRT beim Mammakarzinom. Fortschr Röntgenstr 6:518-523
9. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ (1995) Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 33:506-514
10. Honkoop AH, Pinedo HM, De Jong JS, Verheul HM, Linn SC, Hoekman K, Wagstaff J, van Diest PJ (1997) Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 107:211-218
11. Ikeda T, Jinno H, Matsu A, Masamura S, Kitajima M (2002) The role of neoadjuvant chemotherapy for breast cancer treatment. Breast Cancer 9:8-14
12. Junkermann H, von Fournier D (1997) Bildgebende Verfahren zur Beurteilung des Ansprechens des Mammakarzinoms auf eine präoperative Chemotherapie. Radiologe 37:726-732
13. Knopp MV, Obier C, Zuna I, Junkermann H, Hess T, Junkermann I, Brix G, van Kaick G (1998) Multi-Reader-Analyse zur Beurteilung der funktionellen MR-Mammographie. Radiologe 38:307-314
14. Knopp MV, Brix G, Junkermann HJ, Sinn HP (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 2:633-658
15. Knopp MV, Hoffmann U, Brix G, Hawighorst H, Junkermann HJ, van Kaick G (1995) Schnelle Kontrastmitteldynamik zur Charakterisierung von Tumoren. Erfahrungen bei der funktionellen MR-Mammographie. Radiologe 35:964-972
16. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, van Kaick G (1999) Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imag 10:260-266
17. Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, Regge D, Aglietta M (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83:67-76
18. Müller-Schimpfle M, Ohmenhauser K, Sand J, Stoll P, Claussen CD (1997) Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Imaging 7:236-240
19. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193-1199
20. Rieber A, Zeitler H, Rosenthal H, Gorich J, Kreienberg R, Brambs HJ, Tomczak R (1997) MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 70:452-458
21. Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, Samulski TV, Dewhirst MW (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275-1282
22. Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF (1994) Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie. Geburtsh Frauenheilkd 54:552-558
23. Teubner J, Bohrer M, van Kaick G, Georgi M (1993) Echomorphologie des Mammakarzinoms. Radiologe 33:277-286
24. Wasser K, Delorme S, van Kaick G (2001) Nichtinvasive Untersuchung der Mikrozirkulation von neoplastischen Erkrankungen. Onkologe 7:1134-1144
25. Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, Knopp MV, Delorme S (2003) Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 13:80-87
26. Wasser K, Sinn HP, Fink C, Klein SK, Junkermann H, Ludemann HP, Zuna I, Delorme S (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213-1223
27. Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM (2001) MRI vs histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 13:868-875